Top Stories

  • Johnson & Johnson’s experimental COVID-19 vaccine generated a long-lasting immune response in an early study, with all patients forming neutralizing antibodies within 57 days in a hopeful sign that the one-shot vaccine will perform as well as two-dose vaccines in the broader population. The company expects efficacy results from a late-stage trial by early February, and could seek regulatory authorization by March. (Bloomberg)
  • A Trump administration plan to send $200 prescription drug discount cards to millions of seniors has been nixed, with Centers for Medicare and Medicaid Administrator Seema Verma saying in an interview that she doesn’t “anticipate at this time that they’ll be going out.” President Donald Trump announced the plan shortly before the November election, but it was unclear how the cards would be paid for and the plan faced opposition from Congressional Democrats. (Business Insider)
  • Virtual therapy startup Talkspace, which provides services through text and video chat, said it would go public through a merger with Hudson Executive Investment Corp., a special purpose acquisition company, in a $1.4 billion deal. Talkspace, which provides care directly to consumers and through employer health plans, has reported a surge in use during the pandemic. (Stat News)
  • Coronavirus infections among children, teenagers and adults under 25 fell in the summer and then rose from September to mid-December, mirroring trends among adults overall, according to new data from the Centers for Disease Control and Prevention that found that between March 1 and Dec. 12 of last year, COVID-19 incidence has remained lowest among children ages 10 and younger. Researchers said the findings suggest childcare centers and elementary schools can safely operate in-person when safety measures are followed and levels of community spread are low. (The New York Times)

Chart Review

Events Calendar (All Times Local)

01/14/2021
J.P. Morgan Healthcare Conference
Consumer Electronics Show
Medicare Payment Advisory Commission Meeting 10:45 am
Heritage Foundation: Lessons from the Early COVID-19 Response Featuring HHS Secretary Alex Azar 11:30 am
Kaiser Family Foundation Webinar: Early Lessons from the COVID-19 Vaccine Rollout to High Priority Populations 12:00 pm
Politico Live: Fast and Fair? The COVID Vaccine Rollout 1:00 pm
Princeton University and the Brookings Institution Webinar on the Future of Children: Promoting early development 1:00 pm
01/15/2021
J.P. Morgan Healthcare Conference
Medicare Payment Advisory Commission Meeting 9:30 am
Axios: Health Care Affordability and the Next Administration 12:30 pm
National Institute for Health Care Management Foundation Panel on The Challenges of Aging During COVID-19: Long Term Care, Vaccination and Isolation 1:00 pm
01/16/2021
J.P. Morgan Healthcare Conference
View full calendar


The Fastest Growing Brands of 2020

Morning Consult’s Fastest Growing Brands of 2020 is the definitive measure of brand growth for both emerging and established brands, showcasing a wide range of companies and products that have accelerated their consumer appeal and awareness in 2020.

Download the report for the full rankings overall and by generation, and for the brands that most increased their brand ID in 2020.

Coronavirus

Vaccines and masks: Biden plan aims to break pandemic cycle
Ricardo Alonso-Zaldivar and Bill Barrow, The Associated Press

Biden hopes his multidimensional strategy, expected to be detailed in a Thursday evening speech, will put the country on the path to recovery by the end of his first 100 days.

Amid last minute changes and funding shortfalls, Biden adviser predicts a slow start to the ‘100 million vaccines in 100 days’ goal
Nicholas Florko, Stat News

President-elect Joe Biden is promising to administer 100 million doses of Covid-19 vaccine in his first 100 days — but some of his top advisers are already warning that the early days of that effort are going to be rocky.

US researchers say they have found new coronavirus variants
Kiran Stacey, Financial Times

Researchers in the US have discovered two new variants of coronavirus, one of which they say has become the dominant strain in the state of Ohio’s capital, Columbus, within just three weeks.

CDC Mulls Easing Curbs on EU, Brazil Travel as Covid Tests Begin
Emma Court and Alan Levin, Bloomberg

The Centers for Disease Control and Prevention is weighing new measures that could allow for expanded travel after unveiling Covid-19 testing requirements for people flying into the U.S., said Martin Cetron, director of the agency’s division of global migration and quarantine.

Cash, Breakfasts and Firings: An All-Out Push to Vaccinate Wary Medical Workers
Rebecca Robbins et al., The New York Times

Some staff in hospitals and long-term care facilities don’t want to take the Covid-19 vaccine. Their employers are trying to change their minds.

Health and tech groups aim to create digital Covid ‘vaccination passport’
Hannah Kuchler, Financial Times

Health and technology groups are working together to create a digital vaccination passport in the expectation that governments, airlines and other businesses will require proof people have been vaccinated against Covid-19.

Coronavirus cases among lawmakers who sheltered in lockdown show one vaccine dose may not immediately protect against infection
Ben Guarino, The Washington Post

Three members of Congress contracted the coronavirus after sheltering in a crowded room as a pro-Trump mob stormed the Capitol, testing positive despite having been vaccinated against the virus.

States across the U.S. scramble to meet the skyrocketing demand for vaccines.
Karen Zraick and Amanda Rosa, The New York Times

More than 50 million people in the United States who are 65 or older — as well as younger people with underlying conditions — are now cleared to receive a coronavirus vaccine in the wake of the federal government’s abrupt course reversal on who should get priority. But that’s much easier said than done.

China bars two members of WHO coronavirus mission as depleted team reaches Wuhan
Lily Kuo, The Washington Post

A World Health Organization mission to discover the origins of the coronavirus got off to an inauspicious start on Thursday when two members of the team were barred from entering China.

Payers

Obamacare Sign-Ups Steady as Trump Administration Touts Exchange
Sara Hansard, Bloomberg Law

The Trump administration touted its success in getting people enrolled in Obamacare plans for 2021, highlighting how improvements to the federal HealthCare.gov exchange facilitated the sign-ups.

Providers

Vaccine distribution spurs boom in pharmacy jobs
Erica Pandey, Axios

Pharmacy job postings were up 9.7% in December compared with December 2019 levels, according to data from the jobs site Indeed.

Pandemic propels health systems to mull insurer acquisitions, partnerships: JPM21
Samantha Liss, Healthcare Dive

Nearly a year after the first confirmed case of COVID-19 in the U.S., some of the nation’s largest health systems made a case for the need to accelerate toward value-based arrangements and potentially acquiring or partnering with health plans to become an integrated system.

Pharma, Biotech and Devices

Medicare Drug Price Bill Returning to Senate on Democrats’ Watch
Alex Ruoff, Bloomberg Law

The Senate debate over prescription drug pricing will pick up where it left off last year as the chamber undergoes a change in control, a key Democrat said.

Drugmakers sue HHS over 340B advisory opinion in feud over contract pharmacy access
Robert King, Fierce Healthcare

Drug companies AstraZeneca, Eli Lilly and Sanofi filed separate lawsuits seeking to preserve their ability to restrict offering 340B-discounted drugs to contract pharmacies.

Sana Biotechnology, filing for IPO, aims for astronomical valuation
Kate Sheridan, Stat News

After years of rumors, Sana Biotechnology is positioning itself to file for an initial public offering that could give it the largest-ever valuation for a preclinical company in biotech.

Drug Lobby, Eli Lilly Freeze Donations to GOP Election Deniers
Sara Hansard and Jacquie Lee, Bloomberg Law

The powerful pharmaceutical industry joined the growing ranks of corporate America in suspending political donations to Republican lawmakers who voted against certifying the results of the 2020 presidential election.

Biotech Startup Acquisitions Jumped in 2020, Leaving VCs Optimistic for New Year
Brian Gormley, The Wall Street Journal

Acquisitions of biotechnology startups jumped in 2020, as buyers moved upstream to grab promising drugmakers while they were still private and relatively cheap.

Mark Cuban wades into the generic drug shark tank with a new company
Ed Silverman, Stat News

In an unexpected move, the high-profile billionaire has launched the Mark Cuban Cost Plus Drug Company, which its website says is “dedicated to producing low-cost versions of high-cost generic drugs” and claims that everyone will get the same low price for every drug it makes.

Health Technology

Walmart is working on a stealth health-tech venture that could change how you shop
Blake Dodge and Áine Cain, Business Insider

Walmart is building a new health venture through its incubation arm Store No. 8 that it’s hoping will change the way customers shop, Business Insider has learned.

FTC Reaches Settlement With Flo Health Over Fertility-Tracking App
John D. McKinnon, The Wall Street Journal

The Federal Trade Commission reached a settlement with Flo Health Inc., the developer of a widely used period and fertility-tracking app, over allegations that it improperly shared personal data with Facebook and others, including whether users were ovulating.

JPM21: Cerner wants to build a $1B data business as it expands reach into pharma market
Heather Landi, Fierce Healthcare

Building on its acquisition of clinical research company Kantar Health, health IT giant Cerner is setting its sights on building a $1 billion data business for the healthcare and life sciences industries.

What comes after the telehealth boom? Hybrid care models are drawing investor interest
Mario Aguilar, Stat News

Buoyed by the pandemic, 2020 was undoubtedly the year that telehealth turned the corner to mainstream. But for savvy investors, the big question isn’t what’s hot now — it’s what’s the future holds.

Opinions, Editorials and Perspectives

The Trump administration finally did something right in the fight against covid-19
Leana S. Wen, The Washington Post

After nearly a year of failing to contain covid-19, the outgoing Trump administration is finally taking steps that are likely to improve our national pandemic response.

In Search of a Baby, I Got Covid Instead
Anna Almendrala, Kaiser Health News

As I lay in my hospital bed, my roommate’s TV blaring, I started thinking about my daughter’s understanding of death.

Research Reports

Price Transparency and Variation in U.S. Health Services
Nisha Kurani et al., Peterson-KFF Health System Tracker

In this analysis of health services that are fairly standard and often planned, researchers found that the prices of select services — i.e., knee and hip replacements, cholesterol tests, and Magnetic Resonance Imaging (MRIs) — vary widely even within a given geographical region.

General

Judge Rules U.S. Indian Health Service Must Disclose Sex-Abuse Report
Christopher Weaver, The Wall Street Journal

A federal judge ordered the U.S. Indian Health Service to disclose a report detailing the agency’s decadeslong mishandling of a pediatrician who sexually abused Native American boys in his care, thwarting the agency’s efforts to keep the findings secret.

Morning Consult